Gate2Brain
PrivateLast Round
Early Funding
Jun 16, 2026
Est. Valuation
$26.74M
Total Funding Raised
$6.02M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Gate2Brain is a biotechnology company that has developed a peptide-based technology platform for delivering therapeutics across biological barriers, such as the blood-brain barrier.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gate2Brain Comparables
Compare Gate2Brain with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Key2Brain | 85% | |
| Vect-Horus | 83% | |
| D2B3 | 82% | |
Gate2Brain Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 16, 2026 | ||||
| Convertible Debt | Nov 6, 2024 | ||||
| Grant | Dec 21, 2022 | ||||
| Grant | Jan 13, 2022 | ||||
| Grant | Dec 22, 2021 | ||||
Pre Seed | Jul 9, 2020 |
Gate2Brain Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Fundación la Caixa | Grant |
| BStartup Health | Pre Seed |
| University of Barcelona | Grant |
| Center for Technological Development and Innovation | Grant |
| Fundación Botín | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 52% MoM, reaching 1.2K.
- Jun 16, 2026
Raised $8.13M led by Shilpa Medicare Limited.
Gate2Brain Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gate2Brain's valuation, stock price, and market status.